Stay updated on ABP 798 vs. Rituximab in RA Clinical Trial
Sign up to get notified when there's something new on the ABP 798 vs. Rituximab in RA Clinical Trial page.

Latest updates to the ABP 798 vs. Rituximab in RA Clinical Trial page
- ChecktodayChange DetectedThe page now indicates that recruitment is closed and adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating the Intervention/Treatment heading formatting and the revision label to Revision: v3.6.0.SummaryDifference0.3%

- Check8 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a minor version update to the page, without altering study details.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision label was updated to v3.5.4. This indicates a minor system/template update and does not change study information.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page’s footer/update metadata was bumped to a new revision version (v3.5.3 instead of v3.5.2), reflecting a technical site/version change without modifying the listed study information.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check86 days agoChange DetectedRevision: v3.5.0 deployed to replace v3.4.3. No substantive changes to the study details, eligibility criteria, or results are reflected on the page.SummaryDifference0.0%

Stay in the know with updates to ABP 798 vs. Rituximab in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP 798 vs. Rituximab in RA Clinical Trial page.